(NASDAQ: NDRA) Endra Life Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 36.39%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 54.26%.
Endra Life Sciences's earnings in 2025 is -$8,765,336.On average, 1 Wall Street analyst forecast NDRA's earnings for 2025 to be -$7,775,959, with the lowest NDRA earnings forecast at -$7,775,959, and the highest NDRA earnings forecast at -$7,775,959.
In 2026, NDRA is forecast to generate -$7,527,550 in earnings, with the lowest earnings forecast at -$7,527,550 and the highest earnings forecast at -$7,527,550.